Suchergebnisse - "Sato-Dahlman, Mizuho"

PubPharm (17)

1

Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model

enthalten in: Cancer science | 2023

von Shinoda, S. | Sharma, N. | Nakamura, N. | +5

2

Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2

enthalten in: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery | 2022

von Wirth, K. | Shinoda, S. | Sato-Dahlman, M. | +4

CommentIn: Surg Obes Relat Dis. 2022 Apr;18(4):493-494. - PMID 35131198

3

Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2021

von LaRocca, C. | Salzwedel, A. | Sato-Dahlman, M. | +4

CommentIn: Ann Surg Oncol. 2021 Dec;28(13):8565-8566. - PMID 34423401

4

ASO Visual Abstract: Interferon Alpha-Expressing Oncolytic Adenovirus for the Treatment of Esophageal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2021

von LaRocca, C. | Salzwedel, A. | Sato-Dahlman, M. | +4

5

ASO Visual Abstract: Interferon Alpha-Expressing Oncolytic Adenovirus for the Treatment of Esophageal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2021

von LaRocca, C. | Salzwedel, A. | Sato-Dahlman, M. | +4

6

ASO Visual Abstract: Interferon Alpha-Expressing Oncolytic Adenovirus for the Treatment of Esophageal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2021

von LaRocca, C. | Salzwedel, A. | Sato-Dahlman, M. | +4

7

Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2021

von LaRocca, C. | Salzwedel, A. | Sato-Dahlman, M. | +4

8

Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2021

von LaRocca, C. | Salzwedel, A. | Sato-Dahlman, M. | +4

9

Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma

enthalten in: Annals of surgical oncology | 2021

von LaRocca, C. | Salzwedel, A. | Sato-Dahlman, M. | +4

10

Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells

enthalten in: Translational oncology | 2021

von Yoshida, H. | Sato-Dahlman, M. | Hajeri, P. | +5